CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $27.74M, above the global median of $16.24M
- PositionOperating margin is 34.7%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- Interpretations13 currently firing — 13
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.33%
Annual Rate
JPY 86.00Paid semi-annual
Payout Ratio
54.4%Sustainable
Next Ex-Dividend
Jan 28, 2027
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
46.81BJPY295.46M · vs all stocks (USD)
Trailing P/E
16.40xvs Medical Instruments & Supplies peers
Revenue (TTM)
19.30BJPY121.83M · vs all stocks (USD)
Profit Margin
21.07%vs Medical Instruments & Supplies peers
Beta
0.3500xvs all stocks
52-Week Change
22.37%vs all stocks
Forward Annual Dividend Yield
3.33%vs all stocks
Market Capitalization
46.81BJPY295.46M · vs all stocks (USD)
Enterprise Value
74.43BJPY469.76M · vs all stocks (USD)
Trailing P/E
16.40xvs Medical Instruments & Supplies peers
Forward P/E
18.09xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
3.17xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.35xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.86xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
8.99xvs Medical Instruments & Supplies peers
Profit Margin
21.07%vs Medical Instruments & Supplies peers
Operating Margin
34.65%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
10.19%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
23.64%vs Medical Instruments & Supplies peers
Revenue (TTM)
19.30BJPY121.83M · vs all stocks (USD)
Revenue per Share (TTM)
799.78JPYUpdated Aug 20, 2026Quarterly Revenue Growth
15.80%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
15.19BJPY95.88M · vs all stocks (USD)
EBITDA (TTM)
7.87BJPY49.68M · vs all stocks (USD)
Net Income (TTM)
4.07BJPY25.67M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
36.30%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
5.53BJPY34.88M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
4.39BJPY27.74M · vs all stocks (USD)
Forward Annual Dividend Rate
86.00JPYUpdated Aug 20, 2026Forward Annual Dividend Yield
3.33%vs all stocks
Trailing Annual Dividend Rate
85.00JPYUpdated Aug 20, 2026Trailing Annual Dividend Yield
3.29%vs all stocks
Payout Ratio
54.40%vs Medical Instruments & Supplies peers
Revenue
18.64BJPYFY2026 · Jan 31, 2026Cost of Goods Sold
3.97BJPYFY2026 · Jan 31, 2026Gross Profit
14.67BJPYFY2026 · Jan 31, 2026Operating Income
5.96BJPY37.60M · vs all stocks (USD)
Pre-tax Income
5.62BJPYFY2026 · Jan 31, 2026Income Tax Expense
1.84BJPYFY2026 · Jan 31, 2026Net Income
3.78BJPYFY2026 · Jan 31, 2026EBIT
5.96BJPYFY2026 · Jan 31, 2026EBITDA (Income Statement)
7.87BJPYFY2026 · Jan 31, 2026Selling, General & Administrative
8.72BJPYFY2026 · Jan 31, 2026Other Operating Expenses
40.00MJPYFY2026 · Jan 31, 2026Non-operating Interest Income
5.00MJPYFY2026 · Jan 31, 2026Non-operating Interest Expense
338.00MJPYFY2026 · Jan 31, 2026EPS (Basic)
156.82JPYFY2026 · Jan 31, 2026EPS (Diluted)
154.41JPYFY2026 · Jan 31, 2026Basic Shares Outstanding
24.12MSharesFY2026 · Jan 31, 2026Diluted Shares Outstanding
24.12MSharesFY2026 · Jan 31, 2026Minority Interests (P&L)
0.00JPYFY2026 · Jan 31, 2026Preferred Stock Dividends
0.00JPYFY2026 · Jan 31, 2026Operating Cash Flow
5.38BJPYFY2026 · Jan 31, 2026Free Cash Flow
4.66BJPYFY2026 · Jan 31, 2026Cash & Cash Equivalents (End of Period)
3.05BJPYFY2026 · Jan 31, 2026Starting Profit (CF Statement)
5.62BJPYFY2026 · Jan 31, 2026Other Non-cash Items
306.00MJPYFY2026 · Jan 31, 2026Change in Accounts Receivable (CF)
-150.00MJPYFY2026 · Jan 31, 2026Change in Other Assets/Liabilities
-404.00MJPYFY2026 · Jan 31, 2026Capital Expenditures
-720.00MJPYFY2026 · Jan 31, 2026Net Intangibles (CF)
-1.00MJPYFY2026 · Jan 31, 2026Net Acquisitions
-654.00MJPYFY2026 · Jan 31, 2026Purchase of Investments
-94.00MJPYFY2026 · Jan 31, 2026Sale of Investments
47.00MJPYFY2026 · Jan 31, 2026Net Investing Cash Flow
-1.42BJPYFY2026 · Jan 31, 2026Long-term Debt Issuance
0.00JPYFY2026 · Jan 31, 2026Long-term Debt Payments
-950.00MJPYFY2026 · Jan 31, 2026Common Dividends Paid
-2.07BJPYFY2026 · Jan 31, 2026Other Financing Charges
11.00MJPYFY2026 · Jan 31, 2026Net Financing Cash Flow
-3.01BJPYFY2026 · Jan 31, 2026Shares Outstanding
24.20MSharesUpdated Aug 20, 2026Float Shares
13.79MSharesUpdated Aug 20, 2026% Held by Insiders
39.43%vs all stocks
% Held by Institutions
28.32%vs all stocks
Total Cash (MRQ)
2.33BJPY14.71M · vs all stocks (USD)
Total Cash per Share (MRQ)
96.32JPYUpdated Aug 20, 2026Total Debt (MRQ)
16.21BJPY102.31M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.8864xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.41xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
755.70JPYUpdated Aug 20, 2026Total Assets
39.91BJPY251.90M · vs all stocks (USD)
Total Current Assets
7.34BJPYFY2026 · Jan 31, 2026Total Liabilities
21.72BJPYFY2026 · Jan 31, 2026Total Non-current Assets
32.57BJPYFY2026 · Jan 31, 2026Total Non-current Liabilities
5.15BJPYFY2026 · Jan 31, 2026Total Current Liabilities
16.57BJPYFY2026 · Jan 31, 2026Cash & Cash Equivalents
3.05BJPYFY2026 · Jan 31, 2026Accounts Receivable
1.71BJPYFY2026 · Jan 31, 2026Inventory
2.42BJPYFY2026 · Jan 31, 2026Accounts Payable
709.00MJPYFY2026 · Jan 31, 2026Short-term Debt
13.16BJPYFY2026 · Jan 31, 2026Other Current Liabilities
1.05BJPYFY2026 · Jan 31, 2026Long-term Debt
2.45BJPYFY2026 · Jan 31, 2026Other Non-current Liabilities
503.00MJPYFY2026 · Jan 31, 2026Common Stock (Book)
949.00MJPYFY2026 · Jan 31, 2026Retained Earnings
9.55BJPYFY2026 · Jan 31, 2026Total Shareholders' Equity
18.19BJPY114.79M · vs all stocks (USD)
Treasury Stock
0.00JPYFY2026 · Jan 31, 202652-Week Low
1.82KJPYUpdated Aug 20, 202652-Week High
2.63KJPYUpdated Aug 20, 202652-Week Change
22.37%vs all stocks
Beta
0.3500xvs all stocks
50-Day MA
2.38KJPYUpdated Aug 20, 2026200-Day MA
2.13KJPYUpdated Aug 20, 2026Avg 10-Day Volume
95.08KSharesUpdated Aug 20, 2026Avg 30-Day Volume
122.73KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
154.37JPYUpdated Aug 20, 202613 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Operating income rose four years, with small depreciation on a capital-heavy balance sheet.
Reads
Diagnostic
High OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-Deceleration
Cash covers reported profit and gross profit is up, with margins high and growth slowing.
Reads
Cash-Backed Growth Configuration
Revenue has grown steadily, and the cash arriving matches reported profit.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 34.7%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: 0.35Industry median: 0.12Industry P95: 0.27Peers compared: 65.00
Return on equity is 23.6%, higher than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: 0.24Industry median: 0.06Industry P95: 0.21Peers compared: 65.00
Financial Health
Altman Z-Score 2.31: grey zoneSignificant
Altman Z-Score: 2.31
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $27.74M, above the global median of $16.24MNotable
Levered free cash flow (USD): 27,737,115.301Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Mangalam Cement Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Komatsu Wall Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Tianjin Meiteng Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Huaiji Dengyun Auto Parts Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dongnan Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Integrated Diagnostics Holdings PLC
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Ichikoh Industries, Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Nak Sealing Technologies Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Skymoons Technology
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Suzhou Invotech Scroll Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Companies that share active interpretations — structural patterns currently present in both stocks.
One Career Inc.
12 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsCash-Backed Growth ConfigurationFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthHigh OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-DecelerationIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsMulti-Year Revenue And Profit GrowthMulti-Year FCF With Growth And Margin
Groupe Dynamite Inc.
11 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsCash-Backed Growth ConfigurationRising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthHigh OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-DecelerationThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsMulti-Year Revenue And Profit Growth
Classys Inc.
10 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsMulti-Year Revenue And Profit GrowthMulti-Year FCF With Growth And Margin